Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone in Chronic Rhinosinusitis Without Nasal Polyps
NCT02367118Phase 3Unknown
- Sponsor
- Universidad de Chile
- Start
- Jun 2015
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic rhinosinusitis without nasal polyps (CRSsNP) comparing Prednisone Arm with Placebo Arm (2 arms). Primary endpoints: Sino-Nasal Outcome Test 22 at 6 months, Visual Analogue Scale at 6 months and 4 more. Status: unknown.
02
Drugs
prednisone
03
Conditions
chronic rhinosinusitis without nasal polyps (CRSsNP)
Beyond the preview
Go deeper on NCT02367118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02367118.